Avidity Partners Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-205,000
| Closed | -$16M | – | 84 |
|
|
2024
Q2 | $16M | Buy |
205,000
+45,000
| +28% | +$3.51M | 0.68% | 52 |
|
|
2024
Q1 | $10.8M | Buy |
+160,000
| New | +$10.8M | 0.35% | 70 |
|
|
2023
Q1 | – | Sell |
-1,200,000
| Closed | -$81.4M | – | 84 |
|
|
2022
Q4 | $81.4M | Buy |
1,200,000
+636,800
| +113% | +$43.2M | 1.76% | 18 |
|
|
2022
Q3 | $30.9M | Sell |
563,200
-2,935,800
| -84% | -$161M | 0.63% | 47 |
|
|
2022
Q2 | $231M | Sell |
3,499,000
-201,000
| -5% | -$13.3M | 5.31% | 1 |
|
|
2022
Q1 | $245M | Buy |
3,700,000
+832,800
| +29% | +$55.2M | 5.11% | 1 |
|
|
2021
Q4 | $167M | Buy |
2,867,200
+1,455,200
| +103% | +$84.8M | 3.54% | 5 |
|
|
2021
Q3 | $84.8M | Buy |
+1,412,000
| New | +$84.8M | 1.88% | 13 |
|
|
2021
Q2 | – | Sell |
-3,650,500
| Closed | -$182M | – | 119 |
|
|
2021
Q1 | $182M | Buy |
3,650,500
+1,350,500
| +59% | +$67.1M | 5.01% | 2 |
|
|
2020
Q4 | $115M | Buy |
+2,300,000
| New | +$115M | 3.73% | 5 |
|
|
2020
Q3 | – | Sell |
-325,990
| Closed | -$17.2M | – | 70 |
|
|
2020
Q2 | $17.2M | Buy |
+325,990
| New | +$17.2M | 1.11% | 37 |
|